Completed PHASE3 INTERVENTIONAL 3-arm NCT04339348

Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion

Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Reducing Pain During Levonorgestrel IUD Insertion in Women Delivered Only by Cesarean Deliveries

Sponsor: Cairo University

Conditions Contraception

Interventions Lidocaine-Prilocaine Topical cream placebo vaginal misoprostol

Updated 5 times since 2020 Last updated: May 5, 2021 Started: Apr 30, 2020 Primary completion: Feb 1, 2021 Completion: Mar 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Contraception, this trial is completed. The trial is conducted by Cairo University and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jun 2021 — Jul 2024 [monthly]

Completed PHASE3

Status: Not Yet Recruiting → Completed
Jan 2021 — Jun 2021 [monthly]

Not Yet Recruiting PHASE3
May 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Giza, Egypt